Evoq Remedies (BOM:543500) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies 5-Year EBITDA Growth Rate?

Evoq Remedies's EBITDA per Share for the six months ended in Mar. 2024 was ₹0.40.

During the past 12 months, Evoq Remedies's average EBITDA Per Share Growth Rate was -85.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Evoq Remedies was 327.10% per year. The lowest was -29.30% per year. And the median was 148.90% per year.

Competitive Comparison of Evoq Remedies's 5-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Evoq Remedies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoq Remedies's 5-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's 5-Year EBITDA Growth Rate falls into.

Evoq Remedies 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Evoq Remedies (BOM:543500) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Evoq Remedies 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines